跳至主要内容
临床试验/NCT05120869
NCT05120869已完成不适用

Implementing Innovative and Strategic Approaches to Prevent and Mitigate the Deleterious Effects of HPV Across the Lifespan of Hispanics of Mexican Origin: Healthcare Provider Intervention

University of Texas, El Paso2 个研究点 分布在 1 个国家目标入组 161 人开始时间: 2023年12月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
161
试验地点
2
主要终点
Healthcare Provider (HCP) Practices Scale Score

研究概览

简要总结

Healthcare providers (HCP) serving the El Paso U.S.-Mexico Border Region will be recruited to compare educational and professional skills interventions focused on the human papillomavirus (HPV). Our hypothesis is that improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among the populations they serve.

详细描述

A sample of emerging [in training] and current [in practice] health professionals from the El Paso U.S.-Mexico Border Region will be recruited to participate in a human papillomavirus (HPV) educational and professional skills intervention. Hypothesis: improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among eligible individuals through a tailored multi-media intervention to strengthen providers' ability to discuss HPV and vaccination in an informed and culturally competent manner, and increase subsequent provider recommendations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

盲法说明

  • Participants [blinding]: participants will be randomly assigned to treatment and control groups, they will not be made aware of other participant's receipt of treatment or control materials. Participants will be asked not to discuss this project outside of the intervention; delivery of the intervention or other educational materials will be virtual, limiting the ability of participants to interact with one another during the study.
  • Outcome assessor [blinding]: to reduce bias in the implementation and assessment of the clinical trial, participant information and pre-post survey responses will be maintained separately from the assignment and delivery of the intervention.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Current (in practice) or emerging (in training - medical student, resident, or fellow) healthcare provider
  • •Working/training or living in the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico)
  • •Have the authorization to recommend/prescribe/administer the HPV vaccine

排除标准

  • •Unaffiliated with the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico)
  • •Participation in Phases I or II of the larger research project [cross-sectional phases]
  • •Does not identify as a current or emerging healthcare provider
  • •Declines or is unable to participate in the full intervention and follow-up time-points
  • •Unable to complete participation and activities in the English language

研究组 & 干预措施

Control

Active Comparator

General/publicly available educational materials on HPV and communication skills.

干预措施: General HPV Education and Communication Skills Control Group (Behavioral)

Treatment

Experimental

A tailored HPV education and professional skills intervention.

干预措施: Tailored HPV Education and Professional Skills Intervention Group (Behavioral)

结局指标

主要结局

Healthcare Provider (HCP) Practices Scale Score

时间窗: Baseline

Healthcare provider practices score were assessed using an 8-item Healthcare Provider (HCP) Practices scale from the Healthcare Personnel Survey. The scale evaluated healthcare providers' HPV vaccine recommendation practices, HPV screening recommendation practices, and communication practices. Items were scored on a 5-point Likert scale ranging from Never (1) to Always (5). Healthcare provider practices score is the average score over the 8 items, ranging from 1 to 5, with higher scores indicating better (more frequent engagement in recommended healthcare provider practices related to HPV prevention and screening).

Healthcare Provider (HCP) Practices Scale Score

时间窗: 3 months post intervention

Healthcare provider practices score were assessed using an 8-item Healthcare Provider (HCP) Practices scale from the Healthcare Personnel Survey. The scale evaluated healthcare providers' HPV vaccine recommendation practices, HPV screening recommendation practices, and communication practices. Items were scored on a 5-point Likert scale ranging from Never (1) to Always (5). Healthcare provider practices score is the average score over the 8 items, ranging from 1 to 5, with higher scores indicating better (more frequent engagement in recommended healthcare provider practices related to HPV prevention and screening).

Healthcare Provider (HCP) Practices Scale Score

时间窗: 6 months post intervention

Healthcare provider practices score were assessed using an 8-item Healthcare Provider (HCP) Practices scale from the Healthcare Personnel Survey. The scale evaluated healthcare providers' HPV vaccine recommendation practices, HPV screening recommendation practices, and communication practices. Items were scored on a 5-point Likert scale ranging from Never (1) to Always (5). Healthcare provider practices score is the average score over the 8 items, ranging from 1 to 5, with higher scores indicating better (more frequent engagement in recommended healthcare provider practices related to HPV prevention and screening).

次要结局

  • Human Papillomavirus (HPV) Attitude Score(Immediately post-intervention (0 months).)
  • Human Papillomavirus (HPV) Knowledge Score(Immediately post-intervention (0 months).)

研究者

发起方
University of Texas, El Paso
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eva M. Moya, PhD, LMSW

Professor

University of Texas, El Paso

研究点 (2)

Loading locations...

相似试验